Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 25.06.2024
Meyer Burger Technology AG
Ad hoc announcement pursuant to Art. 53 LR
Thun, Switzerland – June 25, 2024
Meyer Burger makes significant progress in relocating its core business to the USA
Ramp-up of solar module production in Goodyear, Arizona, begins following successful factory audit.
Strategic partnership with leading U.S. technology group to expand activities in the U [ … ]
Mon, 24.06.2024
Birkenstock Holding plc
PRESS RELEASE
LONDON, UNITED KINGDOM || JUNE 24, 2024
BIRKENSTOCK ANNOUNCES LAUNCH OF SECONDARY OFFERING
Birkenstock Holding plc (“BIRKENSTOCK”, the “Company” or “we”, NYSE: BIRK) announced today the commencement of an underwritten secondary public offering of 14,000,000 of BIRKENSTOCK’s ordinary shares (the “Ordinary Shares”) by BK LC Lux Mid [ … ]
Mon, 24.06.2024
Birkenstock Holding plc
PRESS RELEASE
LONDON, UNITED KINGDOM || JUNE 24, 2024
BIRKENSTOCK ANNOUNCES LAUNCH OF SECONDARY OFFERING
Birkenstock Holding plc (“BIRKENSTOCK”, the “Company” or “we”, NYSE: BIRK) announced today the commencement of an underwritten secondary public offering of 14,000,000 of BIRKENSTOCK’s ordinary shares (the “Ordinary Shares”) by BK LC Lux Mid [ … ]
Mon, 24.06.2024
CureVac
CureVac Announces Voting Results of General Meeting
TÜBINGEN, Germany/BOSTON, USA – June 24, 2024 – CureVac N.V. (Nasdaq: CVAC), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced the voting results of the Company's annual general mee [ … ]
Mon, 24.06.2024
R-LOGITECH S.A.M.
Monaco, 24th June 2024 – R-Logitech S.A., a subsidiary of R-Logitech S.A.M. based in Luxembourg, has completed the sale of a portion of its shares in Thaumas N.V. to its co-shareholders in Thaumas, PMV and SFPIM (as purchasers). The sale is made on the basis of an agreement with its co-shareholders on a share purchase and joint resale of such porti [ … ]
Mon, 24.06.2024
VIB Vermögen AG
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014 (Market Abuse Regulation)
Amount of cash compensation for merger squeeze-out at BBI Bürgerliches Brauhaus Immobilien Aktiengesellschaft set at EUR 14.96 per share VIB Vermögen AG, Tilly-Park 1, 86633 Neuburg/Donau, June 24, 2024
VIB Vermögen AG, Neuburg an [ … ]
Mon, 24.06.2024
Airbus SE
Ad-hoc release, 24 June 2024
Airbus provides 2024 guidance update
Charges of around € 0.9bn reported on certain telecommunications, navigation and observation space programmes
A320 ramp-up trajectory adjusted to reflect specific supply chain challenges in a degraded operating environment; around 770 commercial aircraft deliveries now expec [ … ]
Mon, 24.06.2024
CPI PROPERTY GROUP
CPI Property Group
(société anonyme)
40, rue de la Vallée
L-2661 Luxembourg
R.C.S. Luxembourg: B 102 254Press Release - Corporate News
Luxembourg, 24 June 2024CPI PROPERTY GROUP – Update on Poland Equity Investment
CPI PROPERTY GROUP (“CPIPG” or the “Group”) is pleased to announce further progress in the Group’s strategy to reduce leverage.
Today, [ … ]
Mon, 24.06.2024
Merck KGaA
Disclosure of inside information pursuant to Article 17 of Regulation (EU) No 596/2014
Merck KGaA: Phase III trials of xevinapant in locally advanced head & neck cancer discontinued
Darmstadt, June 24, 2024: Merck KGaA is investigating a treatment of xevinapant plus platinum-based chemotherapy (CRT), compared to placebo plus CRT, in patients [ … ]
Mon, 24.06.2024
Merck KGaA
Disclosure of inside information pursuant to Article 17 of Regulation (EU) No 596/2014
Merck KGaA: Phase III trials of xevinapant in locally advanced head & neck cancer discontinued
Darmstadt, June 24, 2024: Merck KGaA is investigating a treatment of xevinapant plus platinum-based chemotherapy (CRT), compared to placebo plus CRT, in patients [ … ]